YHR2501

· Yuhan Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YHR2501, covering 2025-07-24 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study Between YHP2406 and YHR2501 in Healthy Subjects [Phase 1]